Opioid Makers May Have To Pay For Prevention Costs Of 'Man-Made Plague,' Judge Suggests
Bellwether trial set to begin in September after judge says cities may be able to recover damages for cost of governmental services that are the result of defendants' alleged conduct.
You may also be interested in...
Expert witness "battle plan," requests for summary judgment, and squabble over DEA drug distribution data offer preview of the first US bellwether trial against opioid manufacturers, distributors and pharmacies.
Business fundamentals took a back seat to opioid litigation in the second quarter for generic drug makers, including Teva, Mallinckrodt and Endo Pharmaceuticals.
In opening statements, Oklahoma suggests award could be 'just shy of $13bn' if it takes 20 years to fix the problem.